Postdoctoral Scholar - Limoli Lab

The Department of Radiation Oncology at the University of California, Irvine -School of Medicine and Dr. Charles Limoli, Professor and Vice Chair of the Radiation Oncology Department invites applications for the position of Postdoctoral Scholar (Employee, Fellow, Paid Direct, Interim). The Postdoctoral Scholar's first appointment shall be for a minimum of one-year term, provided that there is work, programmatic need, and appropriate funding. This position will be available for 2-3 years funded by National Institutes of Health (NIH), if incumbent is reappointed.

The scholar will be responsible for investigating the efficacy of radiation- and/or chemotherapy-induced tumor cell kill and normal tissue sparing in the CNS and other peripheral organ sites. Our laboratory employs cutting-edge cancer therapy paradigms with a focus on ultra-high dose rate "FLASH" radiotherapy, gene silencing, transgenic, stem cell-based and pharmacological approaches to study neurobiological mechanisms and regenerative strategies to ameliorate a wide range of normal tissue toxicities, neuroinflammation and cognitive impairments.

The successful candidate will possess an excellent track record and a high level of motivation to conduct independent experiments and work well with a team. This position will play an integral role in the execution of the overall aims of several funded NIH grants focused on the translational potential of FLASH radiotherapy, stem cell and extracellular vesicles based strategies to enhance the therapeutic index of cancer treatments in the CNS, lung and head and neck. The candidate will also be expected to be familiar with statistics and the analysis and preparation of data sets for presentations in scientific meetings and peer-reviewed publications.

This role reports directly to the Vice Chair of Radiation Oncology.

This position is dependent on extramural funds and may be subjected to the disposition/availability of such funds. The University of California, Irvine is an Equal Opportunity/Affirmative Action Employer advancing inclusive excellence. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age, protected veteran status, or other protected categories covered by the UC nondiscrimination policy.

Located at the University of California, Irvine Campus in Irvine, California, the Department of Radiation Oncology is an integral part of the NCI-designated Chao Family Comprehensive Cancer Center. The Department is equipped with a robust blend of technology, including a dedicated HDR brachytherapy suite and an intraoperative unit. Further equipment upgrades are planned. The Department features a four-year Radiation Oncology residency training program and a two-year Medical Physics residency. The Department has an active Radiation Biology Division that currently ranks among the top programs in the nation concerning NIH funding. The Department participates in NRG/RTOG and SWOG and encourages investigator-initiated clinical and translational trials. The Division has undergone a transformative change with current and future site expansion in recent years.

Founded in 1965, the University of California, Irvine is the youngest member of the prestigious Association of American Universities. The campus has produced 3 Nobel laureates and is known for its academic achievement, premier research, innovation, and anteater mascot. The University has more than 36,000 students and offers 222 -degree programs. It is located in one of the world's safest and most economically vibrant communities and is Orange County's second-largest employer. The "OC" offers a multitude of recreational and cultural opportunities and is home to Disneyland, as well as to the beach enclaves of Laguna Beach, Newport Beach, and Huntington Beach ("Surf City USA").

The University of California, Irvine is an Equal Opportunity/Affirmative Action Employer advancing inclusive excellence. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age, protected veteran status, or other protected categories covered by the UC nondiscrimination policy.

All applicants of academic positions at the University of California, Irvine must download, complete, sign, and upload the following form with their application:

Sexual Misconduct, Harassment and Discrimination Declaration Form

Application Procedure: Applicants must complete an online application profile and upload the following applications

materials electronically to be considered for the position at: https://recruit.ap.uci.edu/apply/JPF09381

* 5 References (Required)

* Curriculum Vitae (Required)

* Cover Letter (Required)

* Research Statement (Required)

* Inclusive Excellence Activities Statement/Contributions to Diversity (Required)

* Sexual Misconduct, Harassment and Discrimination Declaration Form (Required)

Professor Charles Limoli

Vice Chair of Research and Academic Affairs

Department of Radiation Oncology

Medical Sciences I, B-146B

University of California, Irvine

Irvine, CA 92697-2696

climoli@uci.edu

Applicants must possess a Ph.D. degree and laboratory experience in neuroscience, cancer biology, molecular biology, and/or biochemistry.

• 5 required (contact information only)

The University of California, Irvine is an Equal Opportunity/Affirmative Action Employer advancing inclusive excellence. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age, protected veteran status, or other protected categories covered by the UC anti-discrimination policy.

As a University employee, you will be required to comply with all applicable University policies and/or collective bargaining agreements, as may be amended from time to time. Federal, state, or local government directives may impose additional requirements.